X

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Associate Director - CMC, Drug Substance

Bioprocess & BiomanufacturingConfirmed live in the last 24 hours
Full-timeBoston, MA, USA

About the Job

Requirements

  • A PhD in Chemistry or another relevant discipline and at least 10 years of directly related experience in a pharmaceutical or biotechnology environment; candidates with an MSc and significant relevant experience may be considered.
  • A track record of managing development-stage and/or commercial-stage active pharmaceutical ingredient (API) manufacturing activities at contract development and manufacturing organizations (CDMOs), especially initial current Good Manufacturing Practice (cGMP) deliveries followed by technology transfers to later-stage development CDMOs.
  • Experience authoring or co-authoring key Chemistry, Manufacturing, and Controls (CMC) sections in U.S. Investigational New Drug (IND) and New Drug Application (NDA) filings and European Marketing Authorization Application (MAA) filings for small-molecule APIs.
  • Extensive knowledge of cGMP-related regulations, guidance documents, principles, and best practices relevant to APIs.
  • Experience working in a virtual manufacturing setting, including knowledge of the CDMO landscape, selection, vendor management, contracting, and issue resolution and management.
  • Ability to communicate with scientific and non-scientific personnel and experience applying risk-based decision-making tools.
  • Ability to manage multiple competing priorities and work independently and collaboratively as part of a multidisciplinary team.
  • Ability to apply science- and data-driven approaches, creative thinking, and flexibility to strategic thinking and problem solving.
  • Ability and willingness to travel up to 15% of the time, domestically and internationally.

Responsibilities

  • Manage and oversee the development and manufacturing of small-molecule APIs in accordance with applicable quality and regulatory standards.
  • Evaluate, recommend, and manage qualified CDMOs manufacturing APIs for clinical trials and commercial use.
  • Collaborate with the internal process chemistry team to manage API process technology transfer to CDMOs, including process development and establishment of suitable API specifications.
  • Work with Supply Chain and CMC Drug Product colleagues to translate clinical demand forecasts into API manufacturing plans.
  • Author, with Technical Writing, or serve as a key reviewer of core CMC documents and modules, submissions, and responses to the FDA and other competent authorities, providing strategic oversight and consistency for regulatory interactions, including IND, NDA, MAA, and Investigational Medicinal Product Dossier (IMPD) filings and updates.
  • Participate in and manage API-related budget proposals and approved project budgets in accordance with the Company's strategic and operating plans and Finance policies.
  • Serve as the subject matter expert in audits and inspections of API CDMOs in conjunction with Quality Assurance.
  • Act in accordance with Company policies, including the Code of Business Conduct and Ethics and Intellectual Property policies, and ensure policies are understood and followed by direct reports.
  • Perform other duties as assigned.

About the Company

Xenon Pharmaceuticals

Clinical-stage neurological disorder therapeutics developer

Xenon Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing therapies for neurological disorders, especially epilepsy, through research and collaboration with partners and licensors to support eventual product commercialization. Its drug candidates are designed to treat CNS and genetic contributors to disease, with examples like XEN007 reaching Phase 2 proof-of-concept in treatment-resistant pediatric childhood absence epilepsy, illustrating targeted therapeutic development. The company concentrates on genetics-informed neurology and maintains a pipeline funded in part by partnerships and licensing, setting it apart from broader pharma players. Its goal is to discover, develop, and bring therapies to patients to address unmet needs in neurology and epilepsy.

Company size
201-500
Company stage
IPO
Headquarters
Burnaby, Canada
Founded
1996

Recently Posted Jobs

Explore more opportunities at Xenon Pharmaceuticals

See more jobs